NIPER Raebareli and AstraZeneca India Partner to Strengthen Clinical Research Capabilities Across 25 Emerging Geographies

NIPER Raebareli and AstraZeneca India Partner to Strengthen Clinical Research Capabilities Across 25 Emerging Geographies

Get latest articles and stories on India at LatestLY. The Ministry of Chemicals and Fertilizers said that the MoU was signed in the presence of Manoj Joshi, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers in New Delhi on Wednesday. This collaboration furthers the vision of Biopharma SHAKTI, the Government of India’s flagship initiative to build a stronger biopharma ecosystem, including setting up 1,000 clinical tr…

NIPER Raebareli, AstraZeneca India partner on 25 trial sites

NIPER Raebareli and AstraZeneca India have partnered to train personnel and prepare clinical trial sites across 25 emerging research locations.

NIPER Raebareli & AstraZeneca Team Up to Transform India’s Clinical Trials

The National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, has joined forces with AstraZeneca India to decentralise and supercharge the nation’s clinical research capabilities. Backed by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers, this strategic partnership aims to build a robust network of trained workforces and inspection-ready sites across 25 emerging geographies, […] The post NIPER Raeba…

NIPER Raebareli, AstraZeneca India partner to expand clinical trial sites across India

The collaboration will assess and support 25 clinical trial sites across emerging research geographies, with training, mentoring and site-readiness measures

NIPER Raebareli, AstraZeneca partner to expand clinical trials to 25 emerging hubs

New Delhi, Oct 14 (SocialNews.XYZ) The National Institute of Pharmaceutical Education and Research (NIPER), Raebareli and AstraZeneca India have collaborated to expand clinical trial capabilities beyond metros to strengthen India's clinical research capabilities and increase... - Social News XYZ